본문 바로가기
  • Home

A Study on Inclination of Mind(心慾) and Nature & Emotion(性情) of Sasang Constitutional Medicine

  • Journal of Sasang Constitutional Medicine
  • Abbr : J Sasang Constitut Med
  • 2004, 16(2), pp.17-31
  • Publisher : The Society Of Sasang Constitutional Medicine
  • Research Area : Medicine and Pharmacy > Korean Medicine
  • Received : August 31, 2004
  • Accepted : August 31, 2004
  • Published : August 1, 2004

HWANG MINWOO 1 Lee Sookyung 1 Koh Byung-Hee 2 Song Il Byung 1

1경희대학교
2경희대학교 한의과대학 사상체질과

ABSTRACT

1. Objectives This research is purposed to find Lee Je-Ma's thought on Inclination of Mind(心慾) and Nature & Emotion(性情), through summarizing sentences related to Inclination of Mind(心慾) and Nature & Emotion(性情) proposed in the chief writings on Sasang Constitutional Medicine. 2. Methods It was researched bibliologically with Lee Je-Ma's chief writings such as 『Gyukchigo (Draft on Inquiring the Properties of Things, 格致藁)』, 『Dongyi Suse Bowon Sasang Chobongyun(東醫壽世保元四象草本卷)』『Dongyi Suse Bowon (Longevity and Life Preservation in Oriental Medicine, 東醫壽世保元)』. 3. Results and Conclusions (1) Lee Je-Ma'sMind(心) is the dimension of the Great Absolute(Taegeuk,太極), and is related with Benevolence- Righteousness-Propriety-Wisdom(仁義禮智) (2) Human being is classified Taeyangin(太陽人), Taeumin(太陰人), Soyangin(少陽人), Soeumin(少陰人) by SungLi(性理), and The Mean(鄙人), TheWeek(薄人), The Avaricious(貪人), The Sycophantic(懦人) by JungYok(情 慾) in Sasang Constitutional Medicine. (3) Nature & Emotion(性情) of Sorrow-Anger-Joy-Pleasure(喜怒哀樂) is divided into two function. One is native function related with SungLi(性理), the other is acquired function related with JungYok(情慾). Also all two native and acquired function is related with Benevolence-Righteousness-Propriety-Wisdom(仁義禮智). (4) The Mean(鄙人), TheWeek(薄人), The Avaricious(貪人), The Sycophantic(懦人) may be defined as the state of Inclination of Mind(心慾) of Taeyangin(太陽人), Taeumin(太陰人), Soyangin(少陽人), Soeumin(少陰人) by function of acquired Emotion(情).

Citation status

* References for papers published after 2022 are currently being built.